Table 2. Risk factor control at baseline and follow-up.

Variable	Non-HDL cholesterol (mg/dl)
	≦140 (n = 38)			141–169 (n = 42)			≧170 (n = 39)
	Baseline	8-month	p value	Baseline	8-month	p value	Baseline	8-month	p value
Non-HDL cholesterol	122 ± 14	87 ± 19	< 0.001	155 ± 8	108 ± 23	< 0.001	197 ± 29	127 ± 24	< 0.001
(mg/dl)	Δ	− 35 ± 19			− 48 ± 23			− 69 ± 26
LDL cholesterol	100 ± 15	67 ± 18	< 0.001	132 ± 13	87 ± 21	< 0.001	162 ± 28	100 ± 24	< 0.001
(mg/dl)	Δ	− 33 ± 19			− 45 ± 21			− 62 ± 22
Triglycerides (mg/dl)	98 ± 30	89 ± 32	0.12	122 ± 51	109 ± 51	0.18	174 ± 79	151 ± 81	0.15
	Δ	− 8 ± 34			− 12 ± 58			− 23 ± 99
HDL cholesterol	48 ± 12	54 ± 14	0.001	47 ± 12	51 ± 13	0.06	45 ± 10	48 ± 10	0.04
(mg/dl)	Δ	5 ± 9			4 ± 13			4 ± 11
Apo A-I (mg/dl)	119 ± 22	133 ± 27	< 0.001	118 ± 19	134 ± 26	< 0.001	117 ± 19	129 ± 22	0.002
	Δ	15 ± 18			16 ± 23			12 ± 21
Apo B (mg/dl)	80 ± 10	60 ± 13	< 0.001	103 ± 8	75 ± 15	< 0.001	128 ± 16	85 ± 15	< 0.001
	Δ	− 19 ± 14			− 28 ± 14			− 43 ± 15
hs-CRP (µg/ml)	2.4 [0.8, 7.0]	0.6 [0.3, 2.4]	0.007	3.9 [0.8, 7.6]	0.4 [0.2, 1.3]	< 0.001	5.7 [2.4, 12.3]	0.8 [0.4, 2.1]	< 0.001
	Δ	− 0.8 [− 4.5, − 0.1]			− 2.7 [− 6.8, − 0.5]			− 3.1 [− 8.3, − 1.9]

Values are mean ± SDs or median [interquartile range]; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein